Skip to main content

Table 2 Synopsis of patients undergoing primary RPLND

From: Is there still a place for retroperitoneal lymph node dissection in clinical stage 1 nonseminomatous testicular germ-cell tumours? A retrospective clinical study

Patient (#)

Primary tumour: % teratoma

Primary tumour: Vascular inavasion

Individual reason for RPLND

Surgical result: nodes involved/nodes excised (n/n)

Additional treatment

Outcome

1

75%

no

Teratoma plus equivocal radiological finding

5/15

2xPEB

NED 8 yr

2

20%

no

Patient’s choice

1/27

F/U

NED 7 yr

3

40%

no

Lupus erythematodes, chronic glomerulonephritis

0/42

F/U

NED 7 yr

4

60%

yes

Teratoma plus equivocal radiological finding

0/27

F/U

NED 6 yr

5

20%

yes

chronic kidney disease due to congenital polycystic disease

0/22

F/U

NED 5 yr

6

40%

yes

Equivocal radiological findings

0/30

F/U

NED 4 yr

7

50%

no

Patient’s choice

0/26

F/U

NED 4 yr

8

10%

yes

Equivocal radiological findings

1/33

F/U, NHL 1 year later

AWSM 1 yr

9

95%

no

Teratoma plus equivocal radiological finding

0/24

F/U

NED 3 yr

10

60%

no

Patient’s choice

0/39

F/U

NED 3 yr

11

90%

no

Teratoma plus equivocal radiological finding

1/29

F/U

NED 2 yr

12

0

yes

Patient’s choice

1/10

2x PE

NED 1 yr.

  1. PEB chemotherapy with cisplatin, etoposide, bleomycin; F/U follow-up, NHL Non Hodgkin lymphoma, NED no evidence of disease, AWSM alive with second malignancy, yr years